Prior authorization & UM · Specialty medical-benefit PA
SamaCare
SamaCare is a medical-benefit prior authorization platform for specialty practices. It supports submission, tracking, and insights from real-world authorization data. It is not an enterprise payer UM suite for millions of covered lives.
Strong fit
- Specialty practices buried in medical-benefit drug prior authorizations
- Groups that want submission, tracking, and payer-behavior insight in one workflow
- Organizations measuring time-to-resolution, approval rate, and patient therapy starts
Weak fit
- Payers needing an enterprise UM suite for medical and pharmacy across millions of lives
- Primary care clinics with trivial prior auth volume
- Buyers who will not change how staff work exceptions after submission
Bottom line
SamaCare earns a Recommend for specialty practices whose bottleneck is medical-benefit drug prior authorization. Outcomes claims around faster resolution and higher approval rates are the diligence anchors. Product is narrower than Infinitus voice automation and narrower than Agadia's payer PAHub franchise. Implementation is lighter than a plan UM suite but still needs practice workflow ownership. Pricing for practices is often manufacturer-supported rather than a simple SaaS sticker. Score sits mid-board for a focused specialty fit.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
SamaCare is a medical-benefit prior authorization platform used inside specialty practice workflows. It focuses on submission, tracking, and insights drawn from a large real-world PA dataset.
Compare it with Silna for broader specialty care-readiness work, and with Infinitus when phone follow-up is the missing piece. Payer buyers comparing enterprise UM suites will usually look at Agadia or Xsolis instead.
Score reflects a solid specialty niche with murkier practice-facing price transparency.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| SamaCare | 7.1 | 7.0 |
| Silna Health | 7.3 | 7.1 |
| Infinitus | 7.7 | 7.4 |
| Valer | 6.6 | 6.4 |
| Agadia | 7.6 | 7.2 |
Pricing
| Item | Detail |
|---|---|
| Model | Platform access for specialty practices, commonly supported through pharmaceutical market-access partnerships; commercial terms vary. |
| What usually drives cost | Practice volume, therapeutic areas, and whether manufacturer programs underwrite access. |
| What to ask in diligence | Whether your practice pays directly, what SLAs apply, and how payer mix changes the economics. |
| Published pricing | Public list price: not published. Practices often receive access through manufacturer-supported programs rather than a public SaaS menu. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get SamaCare to function | |
| Specialty practices with meaningful medical-benefit drug PA volume | Low volume makes the platform unnecessary. |
| Staff who will work exceptions inside the PA workflow | Submission-only automation leaves denials untouched. |
| Clarity on how practice access is funded | Manufacturer-supported models need commercial clarity. |
| EHR or practice-management handoff path | Side portals that staff ignore fail. |
| Owners measuring time-to-resolution and therapy starts | Without metrics, PA tools become busywork. |
| What will maximize your value | |
| Track approval rate and days to resolution by payer | Those numbers justify the workflow change. |
| Keep human specialists on complex denials | Full autopilot on hard cases creates patient delays. |
| Use insights on payer behavior to change submission quality | Repeating the same missing data wastes cycles. |
| Retire redundant fax and portal checklists after cutover | Parallel processes hide incomplete adoption. |
| Review patient churn tied to access delays | Access work is a retention problem as much as a billing one. |
| Deal-breakers | |
| You are a payer buying an enterprise UM suite. | |
| Your practice has almost no medical-benefit PA burden. | |
| Staff will not change how they submit authorizations. | |
| Commercial terms for practice access are unclear and unacceptable. | |
| You need phone-hold automation more than specialty PA submission tooling. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contract signed → kickoff | 1-4 weeks (access terms, workflow mapping) |
| 2 | Kickoff → first live workflow | 3-8 weeks for first specialties submitting live |
| 3 | First live workflow → steady value | 2-4 months before approval-rate gains stabilize |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.